Case Report: Complete Remission With Anti−PD−1 and Anti−VEGF Combined Therapy of a Patient With Metastatic Primary Splenic Angiosarcoma

Primary splenic angiosarcoma (PSA) is a rare malignancy with poor prognosis. At present, little study is available on immunotherapy in PSA. Here, we report a case of a patient with metastatic PSA who was treated with programmed death-1 (PD-1) inhibitors and vascular endothelial growth factor (VEGF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Weiran, Wang, Kai, Gu, Wenguang, Nie, Xinxin, Zhang, Hao, Tang, Chuanhao, Lin, Li, Liang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928100/
https://www.ncbi.nlm.nih.gov/pubmed/35311098
http://dx.doi.org/10.3389/fonc.2022.809068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928100/
https://www.ncbi.nlm.nih.gov/pubmed/35311098
http://dx.doi.org/10.3389/fonc.2022.809068

Ejemplares similares